Table 2.
Characteristics of the 14 randomized controlled trials Included in the meta-analysis
Study or author | Baseline LDL-C Level, (mg/dl) | Change in LDL-Ca(mg/dl) | Baseline HDL-C Level,(mg/dl) | Change in HDL-Ca,(mg/dl) | Baseline Triglyceride Level, (mg/dl) |
Change in Triglyceridea,(mg/dl) |
---|---|---|---|---|---|---|
CARDS 2009 [9] | — | — | — | — | — | — |
Masanori 2011 [10] | 137 | −54 | 49 | +4 | 162 | −32 |
Dalla 2003 [11] | 149 | −41 | 55 | +1 | 162 | −32 |
Linda 2001 [12] | 125.5 | −28.3 | 50.9 | +2.2 | 76 | −9.5 |
E. Hommel 1992 [13] | 162.54 | −61.92 | 57.7 | +1.55 | 120.5 | +11.52 |
Lam 1995 [14] | 166.4 | −50.31 | 42.57 | −0.39 | 194.92 | −17.72 |
S.Nielsen 1993 [15] | 170.28 | −58.05 | 48.76 | −0.39 | 204.7 | −20.4 |
Zhang 1995 [16] | 123 | −23 | 62 | +1 | 105 | −12 |
Giancarlo 1997 [17] | 181.89 | −54.18 | 50.31 | 0 | 141.8 | −26.6 |
Tsukasa 2005 [18] | — | — | — | — | — | — |
Tsukasa 2001 [19] | 208 | −62 | 22 | +16 | 202 | −42 |
Wu 2013 [20] | 171.05 | −61.15 | — | — | 225.9 | −65.6 |
Du 2015 [21] | — | — | — | — | — | — |
Xiang 2005 [22] | 166.41 | −19.35 | 54.18 | +7.74 | 221.5 | −17.72 |
aIn statin group;—:not report